Skip to main content

N1BN SECRET ACCOUNT: Whistle blower lied — NPA

N1BN SECRET ACCOUNT: Whistle blower lied — NPA

Ports concession

By Godwin Oritse

THE Management of the Nigerian Ports Authority, NPA, has debunked media reports based on a petition written by one Mr. John Okpurhe to President Muhammadu Buhari alleging that a secret account was being operated by the Authority.

A statement signed by the NPA spokesman, Engr Adams Jatto, said the petitioner accused the Attorney General of the Federation, Mr. Abubakar Malami, SAN, of allegedly refusing to reward him after exposing over $1bn supposedly hidden in an account with Unity Bank Plc.

READ ALSOEdo COVID-19 frontline workers to get outstanding allowance

The statement also said that “the said account number, 0013680344, allegedly being operated by NPA does not exist as evidenced by a letter from the bank, Unity Bank Plc.”

Jatto stated that the allegation lacks substance adding, “Mr. Okpurhe, claiming to be a whistleblower cited an account number, 0013680344,  allegedly being operated by NPA but this account does not exist as evidenced by a letter from Unity Bank Plc.

“The NPA operates an account with Unity Bank Plc with account number: 0013670344 with a total sum of $1,057,772.03 as of December 4, 2019 and not $1,034,515,000.00 as alleged by the petitioner.

“However, the NPA account has not been in operation since August 27, 2010 due to a Suit No: FHC/L/CS/582/2010 Garnishee Order Nisi in Aminu Ibrahim & Co and Anor. VS. Nigerian Ports Authority where a garnishee order was placed on it following a case, which went from the Federal High Court to the Supreme Court over a period of eight years.

“Upon the determination of the case at the Supreme Court, the judgment creditors continued with the Garnishee process which resulted in the credit of the amount $1,057,772.03 in favour of Suit No: FHC/L/CS/582/2010 Garnishee Order Nisi-Aminu Ibrahim & Co and Anor. VS. Nigerian Ports Authority on December 4, 2019 in line with the Garnishee Order absolute.

“It is, therefore, obvious that there is no cloned account as speculated in the alleged whistle blowing effort of Mr. Okpurhe.

“The account under discussion was frozen on the strength of a court order in August 2010, following the completion of the case, the money was consequently transferred to the judgment creditor on December 4, 2019 in line with the Garnishee Order Absolute.”

The post N1BN SECRET ACCOUNT: Whistle blower lied — NPA appeared first on Vanguard News.


by Urowayino Jeremiah via Vanguard News https://ift.tt/3ihPukW Best Known Member of the Cabinet Wikipedia
Labels:

Comments

Post a Comment

Popular posts from this blog

Effective Data Governance: IIM-Africa inks partnership deal with Data Management University

President/Chairman of the governing council of IIM-Africa, Dr. Oyedokun Oyewole has said that effective data governance strategy has become more essential for the survival and sustenance of government and businesses, especially with the sudden outbreak of COVID-19 Pandemic. Oyewole said there is the need to ensure that the right policies, processes, technology, and people are in place to effectively manage data while complying with legal and regulatory requirements. He said that as part of the IIM Africa’s commitments towards ensuring global best practices, it has entered into a long-term partnership with DataManagementU.com to bring the finest data management training to industries across Africa. READ ALSO:  COVID-19: Foreign affairs minister says first set of Nigerians abroad to be evacuated soon According to the IIM President, the alliance is expected to provide members of the Institute and other professionals across Africa, high standards, internationally-recognized learn...
Post a Comment
Read more

Remdesivir: The COVID-19 drug helping patients recover faster

A vial of the investigational drug remdesivir is visually inspected at a Gilead manufacturing site in the United States. PHOTO: AP Remdesivir has been shown to speed up recovery times for patients with COVID-19 in a major US-led trial, becoming the first drug with proven benefit against the disease. Here is what you need to know. – What is remdesivir? – Remdesivir is an experimental, broad spectrum antiviral made by US pharmaceutical Gilead Sciences that was first developed to treat Ebola, a viral hemorrhagic fever. It showed early promise in a primate study in 2016 and was later rolled out for a major trial in the Democratic Republic of Congo, where it was compared against three other medicines. That study concluded in 2019 when it was discontinued because it did not boost survival rates as greatly as two monoclonal antibody drugs, which are lab-engineered immune system proteins. In February, the US National Institute of Allergy and Infectious Diseases (NIAID) announced ...
Post a Comment
Read more

Naomi Osaka’s statement about withdrawing from French Open

Japan’s Naomi Osaka returns the ball to Romania’s Patricia Maria Tig during their first round match of the French open tennis tournament at the Roland Garros stadium Sunday, May 30, 2021 in Paris. (AP Photo/Christophe Ena) Naomi Osaka tweeted the following statement announcing her withdrawal from the French Open on Monday: “Hey everyone, this isn’t a situation I ever imagined or intended when I posted a few days ago. I think now the best thing for the tournament, the other players and my well-being is that I withdraw so that everyone can get back to focusing on the tennis going on in Paris. ”I never wanted to be a distraction and I accept that my timing was not idea and my message could have been clearer. ”More importantly I would never trivialize mental health or use the term lightly. The truth is that I have suffered long bouts of depression since the US Open in 2018 and I have had a really hard time coping with that. Anyone that knows me knows I’m introverted, and anyone tha...
Post a Comment
Read more